No malignant lesions were discovered using this cardiovascular whole-body MRI protocol.
A new form of titanium oxide, a material used in both paint and polo mints, has been discovered using this method.
A series of dimeric inhibitors with two basic P1 moieties was discovered using this design strategy and exhibited tight-binder characteristics.
However, many downstream gene targets of E were unlikely to have been discovered using this approach.
Two new hsp90 inhibitors, celastrol and gedunin, were discovered using this approach [13].
Seven to ten of the possible 56 58 amino acid differences were discovered using this technique.
Although not all of the theoretical differences were discovered using this method, there were enough differences to assign the identity of BoNT/B2 as similar to BoNT/B1, but not as BoNT/B1 a more precise identification than the de facto assignment of BoNT/B1.
Many novel biological concepts have been discovered using this approach, including human disease genes like Duchenne Muscular Dystrophy [ 1], Huntington's [ 2] and Cystic Fibrosis [ 3] but also completely novel classes of biomolecules like microRNAs were identified this way [ 4, 5].
Previously unknown RNA-protein interactions were discovered using this technique, and these interactions were biochemically verified between TP53 mRNA and Staufen1 protein as well as between HRAS mRNA and CNBP protein.
For example, methylation of O 6 -methylguanine DNA methyltransferase (MGMT) in gliO 6 -methylguanineathione S-transferase (GSTP1) in prostate cancer, anDNAutL homethyltransferase colon cancer were discovered using this strategy [ 46– 48].
